SI1146044T1 - CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them - Google Patents

CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
SI1146044T1
SI1146044T1 SI200130181T SI200130181T SI1146044T1 SI 1146044 T1 SI1146044 T1 SI 1146044T1 SI 200130181 T SI200130181 T SI 200130181T SI 200130181 T SI200130181 T SI 200130181T SI 1146044 T1 SI1146044 T1 SI 1146044T1
Authority
SI
Slovenia
Prior art keywords
cyclobuta
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
SI200130181T
Other languages
English (en)
Slovenian (sl)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Francoise Lejeune
Didier Cussac
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of SI1146044T1 publication Critical patent/SI1146044T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200130181T 2000-04-13 2001-04-12 CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them SI1146044T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0004743A FR2807754A1 (fr) 2000-04-13 2000-04-13 Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP01400939A EP1146044B1 (fr) 2000-04-13 2001-04-12 Dérivés de cyclobuta-indole carboxamide agissant sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
SI1146044T1 true SI1146044T1 (en) 2004-12-31

Family

ID=8849213

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130181T SI1146044T1 (en) 2000-04-13 2001-04-12 CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (2) US6452015B2 (no)
EP (1) EP1146044B1 (no)
JP (1) JP3396675B2 (no)
KR (1) KR100470691B1 (no)
CN (1) CN1323796A (no)
AR (1) AR042379A1 (no)
AT (1) ATE275140T1 (no)
AU (1) AU779366B2 (no)
BR (1) BR0101466A (no)
CA (1) CA2344108C (no)
DE (1) DE60105219T2 (no)
DK (1) DK1146044T3 (no)
EA (1) EA004738B1 (no)
ES (1) ES2227082T3 (no)
FR (1) FR2807754A1 (no)
HK (1) HK1040247A1 (no)
HU (1) HUP0101504A3 (no)
NO (1) NO318206B1 (no)
NZ (1) NZ511091A (no)
PL (1) PL347046A1 (no)
PT (1) PT1146044E (no)
SI (1) SI1146044T1 (no)
TR (1) TR200402685T4 (no)
ZA (1) ZA200103064B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933975B1 (fr) * 2008-07-17 2011-02-18 Servier Lab Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
KR20220029900A (ko) * 2020-09-02 2022-03-10 에스케이하이닉스 주식회사 버퍼 회로

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656003A1 (en) * 1992-08-20 1995-06-07 Smithkline Beecham Plc Condensed indole derivatives as 5ht2c and 5ht2b antagonists
GB9306460D0 (en) * 1993-03-29 1993-05-19 Smithkline Beecham Plc Novel compounds
EP0757687A1 (en) * 1994-04-23 1997-02-12 Smithkline Beecham Plc Tricyclic derivatives as 5ht 2c? and 5ht 2b? antagonists
SI0808312T1 (no) * 1995-02-02 2001-02-28 Smithkline Beecham Plc
CA2195346C (en) * 1995-12-21 2007-04-10 Zhi Yuan Wang Benzocyclobutenones and polymers derived therefrom
EP1066036B1 (en) * 1998-02-27 2006-04-26 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea

Also Published As

Publication number Publication date
HUP0101504A2 (hu) 2002-02-28
HUP0101504A3 (en) 2002-11-28
PT1146044E (pt) 2004-11-30
EP1146044A1 (fr) 2001-10-17
NO20011863D0 (no) 2001-04-11
KR20010098581A (ko) 2001-11-08
ATE275140T1 (de) 2004-09-15
KR100470691B1 (ko) 2005-03-07
DE60105219T2 (de) 2005-09-15
JP3396675B2 (ja) 2003-04-14
TR200402685T4 (tr) 2004-11-22
CN1323796A (zh) 2001-11-28
BR0101466A (pt) 2001-12-11
US6452015B2 (en) 2002-09-17
DE60105219D1 (de) 2004-10-07
CA2344108A1 (fr) 2001-10-13
PL347046A1 (en) 2001-10-22
EP1146044B1 (fr) 2004-09-01
ES2227082T3 (es) 2005-04-01
AU779366B2 (en) 2005-01-20
FR2807754A1 (fr) 2001-10-19
EA004738B1 (ru) 2004-08-26
CA2344108C (fr) 2005-11-29
AR042379A1 (es) 2005-06-22
JP2001302661A (ja) 2001-10-31
HU0101504D0 (en) 2001-06-28
DK1146044T3 (da) 2004-12-27
ZA200103064B (en) 2001-10-18
US20010044426A1 (en) 2001-11-22
US6743818B2 (en) 2004-06-01
NO318206B1 (no) 2005-02-14
EA200100344A3 (ru) 2002-02-28
NO20011863L (no) 2001-10-15
HK1040247A1 (zh) 2002-05-31
US20030032812A1 (en) 2003-02-13
AU3518601A (en) 2001-10-18
NZ511091A (en) 2001-09-28
EA200100344A2 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
HUP0301146A3 (en) 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
HUP0300741A3 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
HUP0004123A3 (en) Carboxylic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
IL154096A0 (en) Aporphine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
PL356911A1 (en) Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0204001A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en) Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
SI1118610T1 (en) Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203859A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
SI1245565T1 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
SI1241169T1 (en) Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
SI1176148T1 (en) Benzothiadiazine derivatives, processes for their preparation and pharmaceutical compositions containing them
SI1146044T1 (en) CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
HUP0303110A3 (en) 5-amino-1-pentene-3-ol substituted derivatives, process for their preparation and pharmaceutical compositions containing them and their use
HUP0303238A3 (en) Hiv inhibiting n-aminoimidazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them
HUP0101503A3 (en) Heterocycloalkyl- and heteroaryl-benzocyclobutane derivatives, process for their preparation and pharmaceutical compositions containing them